Published by Michele Maatouk on 3rd August 2026
(Sharecast News) - AstraZeneca is reportedly in talks to combine with US rival Bristol Myers Squibb in a deal that would create one of the world's biggest pharmaceutical groups, valued at nearly $400bn.
URL: http://www.digitallook.com/dl/news/story/36112884/...